• Hypoxia and Immunometabolism in the Tumor Microenvironment

  2026-08-22

  This 2025 review frames tumor hypoxia and immune-cell metabolism as interconnected forces that shape nutrient competition, immune suppression, and malignant progression. Its main practical contribution is a mechanism-based framework for designing experiments and therapies that evaluate oxygen availability, glucose use, and tumor–immune interactions together rather than as isolated variables.

• Reserpine (N1867): Practical Lab Workflow

  2026-08-21

  Reserpine (SKU N1867) provides a characterized research compound for controlled neurotransmitter depletion research, antihypertensive mechanism studies, and neuropharmacology workflows. It is intended for laboratory use only; it should not be used for diagnostic, clinical, therapeutic, or veterinary applications.

• Midecamycin In Vitro Activity: 1983 Study Analysis

  2026-08-20

  Harold C. Neu’s study mapped the in vitro spectrum of midecamycin, an acetoxy-substituted macrolide, across clinically derived gram-positive and gram-negative isolates. The results showed useful activity against many streptococci, staphylococci, Haemophilus influenzae, and Listeria, but lower potency than erythromycin and no reliable activity against erythromycin-resistant strains or most gram-negative bacilli.

• HyperScribe All in One mRNA Synthesis Kit Guide

  2026-08-20

  The HyperScribe All in One mRNA Synthesis Kit is an ARCA capped mRNA synthesis kit that combines T7 transcription, DNase I template removal, and enzymatic poly(A) tailing. Its product specifications support up to 25 reactions and up to 50 μg of RNA per reaction under the stated control-template condition, making it relevant to mRNA vaccine synthesis, in vitro translation mRNA preparation, and RNA interference workflows.

• Sulfo-Cy5 Carboxylic Acid for Mucosal Imaging

  2026-08-19

  Sulfo-Cy5 carboxylic acid combines aqueous compatibility with far-red fluorescence for tracking labeled biomolecules, nanoparticles, and tissue-localization workflows. This guide translates a recent PLGA nano-adjuvant study into practical imaging, labeling, controls, and troubleshooting strategies.

• DAPI Nuclear Stain Solution: Practical Protocol

  2026-08-19

  DAPI (4',6-Diamidino-2-Phenylindole) Nuclear Stain Solution K2402 provides a ready-to-use fluorescent DNA stain for nuclear visualization and endpoint assessment of membrane integrity. It is intended mainly for fixed or membrane-compromised samples analyzed by fluorescence microscopy or flow cytometry, not as a default stain for intact live-cell imaging.

• SU 5402: From RTK Biology to Human Neuron Models

  2026-08-18

  SU 5402 offers translational researchers a way to interrogate receptor tyrosine kinase signaling across cancer biology and emerging human sensory-neuron models. This thought-leadership guide connects FGFR3-linked multiple myeloma research with rigorous pathway validation, assay design, competitive positioning, and responsible cross-domain interpretation.

• N1-Methylpseudouridine for mRNA Workflows

  2026-08-18

  N1-Methylpseudouridine supports high-output mRNA expression while helping researchers investigate innate immune and eIF2α-linked translational constraints. This practical guide connects formulation, cell-based screening, metabolic controls, and troubleshooting for more reproducible research workflows.

• G-Quadruplexes Modulate TDP43 Aggregation and Toxicity

  2026-08-17

  Oldani et al. show that RNA G-quadruplexes influence TDP-43 aggregation, intracellular distribution, and toxicity across biochemical and cellular models. The work provides a mechanistic basis for studying nucleic-acid structure as a modulator of protein misfolding, while also defining important limits for translating G-quadruplex ligands into neurodegeneration research.

• Cabozantinib: Time-Resolved Signaling in RCC

  2026-08-17

  Cabozantinib (XL184) is more than a multi-kinase inhibitor: its cellular effects change with exposure duration. This evidence-focused guide shows how to separate acute target suppression from chronic phosphorylation remodeling, motility adaptation, and assay-specific interpretation in cancer research.

• DeferoxamineB as an Iron-Death Assay Control

  2026-08-16

  DeferoxamineB is more than an iron chelator: it is a mechanistic control for separating iron-dependent lipid damage from copper-driven and other regulated cell-death signals. This article explains how to integrate Deferoxamine into cancer assays, interpret rescue experiments, and avoid confounding antiproliferative, apoptotic, and autophagic effects.

• Tankyrase Inhibition and Hippo Signaling in HCC

  2026-08-15

  Jia et al. show that the tankyrase inhibitors XAV-939 and G007-LK suppress hepatocellular carcinoma cell growth while reducing YAP activity and increasing the Hippo-pathway regulators AMOTL1 and AMOTL2. The study extends tankyrase biology beyond canonical Wnt signaling and provides a mechanistic basis for combining tankyrase inhibition with MEK or AKT pathway blockade.

• Colistin–Gamithromycin Synergy in P. multocida

  2026-08-15

  Li and colleagues showed that combining colistin with gamithromycin can markedly improve activity against Pasteurella multocida, particularly isolates with elevated colistin MICs, in a neutropenic murine pneumonia model. The study links combination efficacy to exposure-based pharmacokinetic/pharmacodynamic analysis and identifies a potentially dose-sparing strategy, while also showing that synergy depends on the bacterial isolate.

• Lipo3K Transfection Reagent for MDR Assays

  2026-08-14

  Discover how Lipo3K Transfection Reagent can support mechanistic gene expression studies and RNA interference research in paclitaxel-resistant breast cancer models. This article translates lipid-mediated delivery into a rigorous assay strategy for testing transporter cooperation, cholesterol-dependent resistance, and causal rescue.

• Canagliflozin for Renal Mitochondrial Research

  2026-08-13

  Canagliflozin enables a practical bridge between renal glucose handling and mitochondrial phenotyping in diabetic kidney models. This workflow combines SGLT2 target engagement, albuminuria, mitochondrial network imaging, and bioenergetics to distinguish glucose-lowering effects from broader proximal tubular protection.

450 records 7/30 page Previous Next First page 上5页 678910 下5页 Last page